Lakefront Biotherapeutics NV (AMS:LKFT)
23.36
-0.04 (-0.17%)
At close: May 12, 2026
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 558 employees as of June 30, 2025. The number of employees decreased by 146 or -20.74% since the number was reported on December 31, 2024.
Employees
558
Change
-146
Growth
-20.74%
Revenue / Employee
€1,482,602
Profits / Employee
€694,288
Market Cap
1.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 558 | -146 | -20.74% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Signify | 26,008 |
| Havas | 21,542 |
| Fugro | 9,062 |
| Basic-Fit | 7,906 |
| TKH Group | 5,954 |
| AMG Critical Materials | 3,640 |
| Corbion | 2,441 |
| Theon International | 767 |
Lakefront Biotherapeutics NV News
- 5 days ago - Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 - GlobeNewsWire
- 6 weeks ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 6 weeks ago - Galapagos Announces Nomination of Gino Santini to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - GlobeNewsWire
- 7 weeks ago - Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 7 weeks ago - Galapagos Receives Transparency Notification from Bank of America - GlobeNewsWire
- 2 months ago - Galapagos Receives Transparency Notifications from Bank of America - GlobeNewsWire